首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
DIRECT LABELING OF RAT M3-MUSCARINIC RECEPTORS BY [H-3] 4DAMP
被引:114
作者
:
MICHEL, AD
论文数:
0
引用数:
0
h-index:
0
机构:
SYNTEX RES,INST PHARMACOL,R2-101,3401 HILLVIEW AVE,PALO ALTO,CA 94303
MICHEL, AD
STEFANICH, E
论文数:
0
引用数:
0
h-index:
0
机构:
SYNTEX RES,INST PHARMACOL,R2-101,3401 HILLVIEW AVE,PALO ALTO,CA 94303
STEFANICH, E
WHITING, RL
论文数:
0
引用数:
0
h-index:
0
机构:
SYNTEX RES,INST PHARMACOL,R2-101,3401 HILLVIEW AVE,PALO ALTO,CA 94303
WHITING, RL
机构
:
[1]
SYNTEX RES,INST PHARMACOL,R2-101,3401 HILLVIEW AVE,PALO ALTO,CA 94303
[2]
GLAXO GRP RES LTD,DEPT NEUROPHARMACOL,WARE SG12 0DP,HERTS,ENGLAND
来源
:
EUROPEAN JOURNAL OF PHARMACOLOGY
|
1989年
/ 166卷
/ 03期
关键词
:
D O I
:
10.1016/0014-2999(89)90359-2
中图分类号
:
R9 [药学];
学科分类号
:
1007 ;
摘要
:
引用
收藏
页码:459 / 466
页数:8
相关论文
共 50 条
[31]
EFFECTS OF LITHIUM ON [QUINUCLIDINYL-H-3 BENZILATE ([H-3](-)QNB) BINDING TO RAT-BRAIN MUSCARINIC CHOLINERGIC RECEPTORS
HRUSKA, RE
论文数:
0
引用数:
0
h-index:
0
机构:
NINCDS,NEUROTOXICOL SECT,BETHESDA,MD 20205
HRUSKA, RE
LUDMER, LM
论文数:
0
引用数:
0
h-index:
0
机构:
NINCDS,NEUROTOXICOL SECT,BETHESDA,MD 20205
LUDMER, LM
PERT, A
论文数:
0
引用数:
0
h-index:
0
机构:
NINCDS,NEUROTOXICOL SECT,BETHESDA,MD 20205
PERT, A
BUNNEY, WE
论文数:
0
引用数:
0
h-index:
0
机构:
NINCDS,NEUROTOXICOL SECT,BETHESDA,MD 20205
BUNNEY, WE
JOURNAL OF NEUROSCIENCE RESEARCH,
1984,
11
(02)
: 171
-
177
[32]
DIRECT VISUALIZATION OF BRAIN M2 MUSCARINIC RECEPTORS USING THE SELECTIVE ANTAGONIST [H-3]AF-DX116
REGENOLD, W
论文数:
0
引用数:
0
h-index:
0
机构:
MCGILL UNIV,FAC MED,DOUGLAS HOSP RES CTR,6875 BLVD LASALLE,VERDUN H4H 1R3,QUEBEC,CANADA
REGENOLD, W
ARAUJO, D
论文数:
0
引用数:
0
h-index:
0
机构:
MCGILL UNIV,FAC MED,DOUGLAS HOSP RES CTR,6875 BLVD LASALLE,VERDUN H4H 1R3,QUEBEC,CANADA
ARAUJO, D
QUIRION, R
论文数:
0
引用数:
0
h-index:
0
机构:
MCGILL UNIV,FAC MED,DOUGLAS HOSP RES CTR,6875 BLVD LASALLE,VERDUN H4H 1R3,QUEBEC,CANADA
QUIRION, R
EUROPEAN JOURNAL OF PHARMACOLOGY,
1987,
144
(03)
: 417
-
419
[33]
[H-3] PIRENZEPINE IDENTIFIES PUTATIVE-M1 MUSCARINIC RECEPTORS IN HUMAN STELLATE GANGLIA
WATSON, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA HLTH SCI CTR, DEPT PHARMACOL, TUCSON, AZ 85724 USA
WATSON, M
ROESKE, WR
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA HLTH SCI CTR, DEPT PHARMACOL, TUCSON, AZ 85724 USA
ROESKE, WR
JOHNSON, PC
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA HLTH SCI CTR, DEPT PHARMACOL, TUCSON, AZ 85724 USA
JOHNSON, PC
YAMAMURA, HI
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV ARIZONA, ARIZONA HLTH SCI CTR, DEPT PHARMACOL, TUCSON, AZ 85724 USA
YAMAMURA, HI
BRAIN RESEARCH,
1984,
290
(01)
: 179
-
182
[34]
CHARACTERIZATION OF [H-3]PIRENZEPINE BINDING TO MUSCARINIC CHOLINERGIC RECEPTORS SOLUBILIZED FROM RAT-BRAIN
LUTHIN, GR
论文数:
0
引用数:
0
h-index:
0
LUTHIN, GR
WOLFE, BB
论文数:
0
引用数:
0
h-index:
0
WOLFE, BB
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
1985,
234
(01)
: 37
-
44
[35]
Signalling of the M3-muscarinic receptor to the anti-apoptotic pathway
Budd, DC
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
Budd, DC
Spragg, EJ
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
Spragg, EJ
Ridd, K
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
Ridd, K
Tobin, AB
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England
Tobin, AB
BIOCHEMICAL JOURNAL,
2004,
381
: 43
-
49
[36]
AUTORADIOGRAPHIC DISTRIBUTION OF MUSCARINIC [H-3] ACETYLCHOLINE-RECEPTORS IN RAT-BRAIN - COMPARISON WITH ANTAGONISTS
QUIRION, R
论文数:
0
引用数:
0
h-index:
0
机构:
MCGILL UNIV,FAC MED,DEPT PSYCHIAT,VERDUN H4H 1R3,QUEBEC,CANADA
MCGILL UNIV,FAC MED,DEPT PSYCHIAT,VERDUN H4H 1R3,QUEBEC,CANADA
QUIRION, R
论文数:
引用数:
h-index:
机构:
BOKSA, P
EUROPEAN JOURNAL OF PHARMACOLOGY,
1986,
123
(01)
: 170
-
172
[37]
[H-3] OXOTREMORINE-M BINDING TO MEMBRANES PREPARED FROM RAT-BRAIN AND HEART - EVIDENCE FOR SUBTYPES OF MUSCARINIC RECEPTORS
BEVAN, P
论文数:
0
引用数:
0
h-index:
0
机构:
SANDOZ LTD,CH-4002 BASEL,SWITZERLAND
SANDOZ LTD,CH-4002 BASEL,SWITZERLAND
BEVAN, P
EUROPEAN JOURNAL OF PHARMACOLOGY,
1984,
101
(1-2)
: 101
-
110
[38]
COCAINE RECEPTORS - INVIVO LABELING WITH H-3 (-)COCAINE, H-3 WIN-35,065-2, AND H-3 WIN-35,428
SCHEFFEL, U
论文数:
0
引用数:
0
h-index:
0
机构:
NIDA,ADDICT RES CTR,NEUROSCI BRANCH,BALTIMORE,MD 21224
NIDA,ADDICT RES CTR,NEUROSCI BRANCH,BALTIMORE,MD 21224
SCHEFFEL, U
BOJA, JW
论文数:
0
引用数:
0
h-index:
0
机构:
NIDA,ADDICT RES CTR,NEUROSCI BRANCH,BALTIMORE,MD 21224
NIDA,ADDICT RES CTR,NEUROSCI BRANCH,BALTIMORE,MD 21224
BOJA, JW
KUHAR, MJ
论文数:
0
引用数:
0
h-index:
0
机构:
NIDA,ADDICT RES CTR,NEUROSCI BRANCH,BALTIMORE,MD 21224
NIDA,ADDICT RES CTR,NEUROSCI BRANCH,BALTIMORE,MD 21224
KUHAR, MJ
SYNAPSE,
1989,
4
(04)
: 390
-
392
[39]
COMPARISON OF (H-3) TERGURIDE AND (H-3) SPIPERONE BINDING TO DOPAMINE-RECEPTORS IN THE RAT STRIATUM
VALCHAR, M
论文数:
0
引用数:
0
h-index:
0
VALCHAR, M
DOBROVSKY, K
论文数:
0
引用数:
0
h-index:
0
DOBROVSKY, K
KREJCI, I
论文数:
0
引用数:
0
h-index:
0
KREJCI, I
DLABAC, A
论文数:
0
引用数:
0
h-index:
0
DLABAC, A
ACTIVITAS NERVOSA SUPERIOR,
1989,
31
(01):
: 77
-
79
[40]
M-4 muscarinic autoreceptor-mediated inhibition of [H-3]acetylcholine release in the rat isolated urinary bladder
DAgostino, G
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
DAgostino, G
Barbieri, A
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
Barbieri, A
Chiossa, E
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
Chiossa, E
Tonini, M
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
UNIV PAVIA,DIV PHARMACOL & TOXICOL,DEPT INTERNAL MED & THERAPEUT,I-27100 PAVIA,ITALY
Tonini, M
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS,
1997,
283
(02)
: 750
-
756
←
1
2
3
4
5
→